New AskBio CEO charts growth strategy


With the backing of parent company Bayer, AskBio is staying focused on finding cures for rare diseases as former CEO and co-founder Sheila Mikhail moves into an advisory role and a new leader takes the helm.

Previous Soft life sciences sector reflects Triangle's flex space challenges
Next Clinical Counseling Associates opens new location in Kansas City's Northland